Type 2 diabetes mellitus among beneficiaries of the French National Health Insurance for self-employed workers (AMPI): Comparison of the management of craftsmen or tradesmen with professionals patients

Diabetes and Metabolism

Volumn 28, Issue 6 I, 2002, Pages 491-498

  Auleley, G R ^a   Dematons, M N ^a   Berchery, P ^a   Raynal Minville, F ^a   Suarez, F ^a   Heuls Bernin, B ^a   Blum Boisgard, C ^a  

^a NONE

Author keywords

Craftsmen or tradesmen categories; Management; Professionals categories; Socio professional category; Type 2 diabetes mellitus

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE DERIVATIVE; HEMOGLOBIN A1C; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; ELECTROCARDIOGRAM; FEMALE; FRANCE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NATIONAL HEALTH INSURANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; REIMBURSEMENT; SCREENING TEST;

EID: 0036937808     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ricordeau P, Weill A, Vanier N, Bourrel R, Fender P, Allemand H. Epidemiology of diabetes in mainland France. Diabetes Metab, 2000, 26, 11-24.
2. Haut Comité de la Santé Publique. Diabètes. Prévention, dispositifs de soins et éducation du patient. Collection Avis et Rapports. Editions ENSP, mai 1998.
3. www.sante.gouv.fr/htm/actu/36_diabet3.htm.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS 33). Lancet, 1998, 352, 837-853.
5. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulino-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-986.
6. UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ, 1998, 317, 703-713.
7. ANAES. Stratégie de prise en charge du patient diabétique de type 2 à l'exclusion de la prise en charge des complications. Diabetes Metab, 1999, 26, 232-243.
8. Agence française de sécurité sanitaire des produits de santé. Recommandations pour le traitement médicamenteux du diabète de type II. Néphrologie, 2000, 21, 75-77.
9. Clinical Practice Recommandations 2001. Diabetes Care, 2001, 24, S1-133.
10. http://journal.diabetes.org.
11. Institute for Clinical Systems Improvement. Management of type 2 diabetes mellitus. www.icsi.org.
12. Meltzer S, Leitner L, Daneman D et al. 1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association. CMAJ, 1998, 159, S1-29.
13. Veterans Health Administration. Clinical practice guideline for the management of diabetes mellitus in the primary care setting. www.va.gouv.
14. Le Floch JP, Thervet F, Desriac I, Boyer JF, Simon D. Management of diabetic patients by general practitioners in France 1997: an epidemiological study. Diabetes Metab, 2000, 26, 43-49.
15. CNAMTS. Programme de santé publique sur la prise en charge du diabète de type 2: la prise en charge des diabétiques exclusivement traités par hypoglycémiants oraux en 1998. CNAMTS. Paris. Octobre 1999.
16. Klein R, Klein BE, Jensen SC, Moss SE. The relation of socioeconomic factors to the incidence of proliferative diabetic retinopathy and loss of vision. Ophtalmology, 1994, 101, 68-76.
17. Obadia G, Lombrail P, Thibut N, Eschwege E, Passa P. Prise en charge hospitalière du diabète insulino-traité chez les Africains en France. Diabetes Metab, 1986, 12, 16-20.
18. Ayanian JZ, Weissman JS, Schneider EC, Ginsburg JA, Zaslavsky AM. Unmet health needs of uninsured adults in the United States. JAMA, 2000, 284, 2061-2069.
19. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depression symptoms on adherence, function, and costs. Arch Intern Med, 2000, 160, 3278-3285.
20. Johnson KH, Bazargan M, Bing EG. Alcohol consumption and compliance among inner-city minority patients with type 2 diabetes mellitus. Arch Fam Med, 2000, 9, 964-970.
21. rd ed. Wiley: Chichester, England, 2000, 91-108.
22. Farmer RDT, Williams TJ, Simpson EL, Nightingale AL. Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of General Practice Research Database. BMJ, 2000, 321, 477-479.
23. Risch HA, Howe GR. Menopausal hormone usage and breast cancer in Saskatchewan: a record-linkage cohort study. Am J Epidemiol, 1994, 139, 670-683.
24. Wagner EH, Sandhu N, Newton KM, McCullough DK, Ramsey SD, Grohans LC. Effect of improved glycemic control on health care costs and utilization. JAMA, 2000, 285, 182-189.